Estimated Health Outcomes and Costs Associated With Use of Monoclonal Antibodies for Prevention or Mitigation of SARS-CoV-2 Infections
10.1001/jamanetworkopen.2022.5750
Saved in:
Main Authors: | Park, Minah, Tan, Kelvin Bryan, Vasoo, Shawn, Dickens, Borame L, Lye, David, Cook, Alex R |
---|---|
Other Authors: | DEAN'S OFFICE (SSH SCH OF PUBLIC HEALTH) |
Format: | Letter |
Language: | English |
Published: |
AMER MEDICAL ASSOC
2023
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/242820 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
The predictors of high titer of anti-SARS-CoV-2 antibody of convalescent plasma donors
by: Shinta Oktya Wardhani, -, et al.
Published: (2021) -
Institutional versus home isolation to curb the COVID-19 outbreak reply
by: Wilder-Smith, Annelies, et al.
Published: (2023) -
Hypertension is associated with antibody response and breakthrough infection in health care workers following vaccination with inactivated SARS-CoV-2
by: Gatot Soegiarto, -, et al.
Published: (2022) -
Hypertension is associated with antibody response and breakthrough infection in health care workers following vaccination with inactivated SARS-CoV-2
by: Gatot Soegiarto, -, et al.
Published: (2022) -
Institutional, not home-based, isolation could contain the COVID-19 outbreak
by: Dickens, Borame L, et al.
Published: (2021)